ARTICLE | Company News
AmorChem, McGill University, Florida Institute of Technology deal
February 4, 2013 8:00 AM UTC
Life science VC fund AmorChem and the universities partnered to develop 5-oxo-ETE receptor antagonists to treat eosinophilic disorders, including severe asthma. AmorChem said the deal will target the...